Bertrand is the Founder and CEO of Genetic Leap, leading the next giant leap in human healthcare with AI technologies for causal gene discovery and precision gene control through RNA-targeted molecules that are potent, safe, convenient, and reversible. The company has multiple promising drug programs at pre-IND stage and has experience collaborating with Pharma.
Prior to founding Genetic Leap, Bertrand was a strategy and management consultant with McKinsey & Company in the New York office where he advised fortune 100 companies across pharma, technology, and finance. Bertrand holds doctorate degrees from Columbia University in Bioengineering and Synthetic Chemistry.
Prior to founding Genetic Leap, Bertrand was a strategy and management consultant with McKinsey & Company in the New York office where he advised fortune 100 companies across pharma, technology, and finance. Bertrand holds doctorate degrees from Columbia University in Bioengineering and Synthetic Chemistry.
Speaking In
3:15 PM - 3:30 PM (EST)
Monday, February 6
Genetic Leap is leading the next giant leap in human healthcare with AI technologies for precise…
Palace
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
